Holen Sie sich die Stockscreener-App
59.72
0.37%
0.22
Handel nachbörslich:
58.57
-1.15
-1.93%
Schlusskurs vom Vortag:
$59.50
Offen:
$59.52
24-Stunden-Volumen:
677.00K
Relative Volume:
1.21
Marktkapitalisierung:
$3.79B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-145.21M
KGV:
-25.97
EPS:
-2.3
Netto-Cashflow:
$-140.12M
1W Leistung:
+8.98%
1M Leistung:
+12.00%
6M Leistung:
+48.19%
1J Leistung:
+25.96%
1-Tages-Spanne:
$56.80
$59.97
1-Wochen-Bereich:
$53.18
$61.87
52-Wochen-Spanne:
$31.42
$61.87
Moonlake Immunotherapeutics Stock (MLTX) Company Profile
Firmenname
Moonlake Immunotherapeutics
Sektor
Branche
Telefon
41 41 510 8022
Adresse
DORFSTRASSE 29, ZUG
Vergleichen Sie MLTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MLTX
Moonlake Immunotherapeutics
|
59.72 | 3.72B | 0 | -145.21M | -140.12M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Moonlake Immunotherapeutics Stock (MLTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-05-19 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2024-11-05 | Fortgesetzt | Wedbush | Outperform |
| 2024-08-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-02 | Eingeleitet | Goldman | Neutral |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Citigroup | Buy |
| 2023-11-02 | Eingeleitet | Stifel | Buy |
| 2023-09-14 | Herabstufung | Bryan Garnier | Buy → Neutral |
| 2023-08-31 | Eingeleitet | Needham | Buy |
| 2023-06-15 | Eingeleitet | Barclays | Equal Weight |
| 2023-05-01 | Eingeleitet | Guggenheim | Buy |
| 2023-03-22 | Eingeleitet | Wedbush | Outperform |
| 2023-03-09 | Eingeleitet | BTIG Research | Buy |
| 2023-02-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-02-02 | Eingeleitet | Bryan Garnier | Buy |
| 2022-11-11 | Eingeleitet | Jefferies | Buy |
| 2022-08-25 | Eingeleitet | SVB Leerink | Outperform |
| 2022-07-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-07 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Moonlake Immunotherapeutics Aktie (MLTX) Neueste Nachrichten
How hedge fund analytics apply to MoonLake Immunotherapeutics stockJuly 2025 Technicals & Real-Time Volume Triggers - Newser
How to use a screener to detect MoonLake Immunotherapeutics breakoutsJuly 2025 Spike Watch & Accurate Intraday Trade Tips - Newser
Will MoonLake Immunotherapeutics price bounce be sustainable2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser
Using data models to predict MoonLake Immunotherapeutics stock movementWeekly Market Outlook & Smart Investment Allocation Tips - Newser
MoonLake Immunotherapeutics stock daily chart insightsJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser
Can technical indicators confirm MoonLake Immunotherapeutics’s reversalQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
What Technical Tools Say About MoonLake Immunotherapeutics RecoveryQuarterly Profit Review & Precise Buy Zone Identification - beatles.ru
MoonLake Immunotherapeutics stock trend outlook and recovery pathWeekly Risk Summary & Free Real-Time Market Sentiment Alerts - Newser
What recovery options are there for MoonLake ImmunotherapeuticsTreasury Yields & Fast Entry High Yield Stock Tips - Newser
MoonLake Immunotherapeutics stock prediction for this weekTreasury Yields & Daily Market Momentum Tracking - Newser
How to track smart money flows in MoonLake ImmunotherapeuticsJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - Newser
Can MoonLake Immunotherapeutics rally from current levelsProduct Launch & Comprehensive Market Scan Reports - Newser
What Fibonacci levels say about MoonLake Immunotherapeutics reboundTrade Exit Report & Growth Focused Entry Reports - Newser
Can a trend reversal in MoonLake Immunotherapeutics lead to recoveryPortfolio Value Summary & High Accuracy Trade Signal Alerts - Newser
Visual analytics tools that track MoonLake Immunotherapeutics performanceWeekly Stock Analysis & Community Verified Trade Signals - Newser
Sentiment analysis tools applied to MoonLake ImmunotherapeuticsJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
What MACD and RSI say about MoonLake ImmunotherapeuticsEarnings Miss & Consistent Growth Stock Picks - Newser
Ranking MoonLake Immunotherapeutics among high performing stocks via tools2025 Year in Review & High Accuracy Trade Alerts - Newser
How sensitive is MoonLake Immunotherapeutics to inflation2025 Price Action Summary & Growth Focused Entry Reports - khodrobank.com
MoonLake Immunotherapeutics stock hits 52-week high at 58.3 USD - Investing.com
Applying chart zones and confluence areas to MoonLake ImmunotherapeuticsDividend Hike & Safe Capital Growth Stock Tips - Newser
Forecasting MoonLake Immunotherapeutics price range with options dataJuly 2025 EndofMonth & High Conviction Buy Zone Picks - Newser
Using economic indicators to assess MoonLake Immunotherapeutics potentialJuly 2025 Action & Momentum Based Trading Ideas - Newser
Published on: 2025-09-02 03:46:56 - Newser
Can MoonLake Immunotherapeutics expand into new marketsOil Prices & Fast Momentum Stock Entry Tips - khodrobank.com
What’s the analyst consensus on MoonLake ImmunotherapeuticsQuarterly Portfolio Report & High Return Trade Guides - khodrobank.com
Is now a turning point for MoonLake ImmunotherapeuticsEarnings Growth Report & Smart Investment Allocation Insights - Newser
Will MoonLake Immunotherapeutics announce a stock splitMarket Performance Report & Precise Buy Zone Identification - khodrobank.com
Is MoonLake Immunotherapeutics forming a bottoming baseAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser
Trend Reversal Possible in MoonLake Immunotherapeutics Charts IndicateJuly 2025 Sentiment & Safe Entry Trade Reports - beatles.ru
2 Small-Cap Biotech Stocks Well Positioned for a Breakout - AOL.com
What institutional flow reveals about MoonLake ImmunotherapeuticsWeekly Trend Report & Long-Term Growth Stock Strategies - Newser
When is the best time to exit MoonLake ImmunotherapeuticsDip Buying & Fast Gain Stock Tips - Newser
Finanzdaten der Moonlake Immunotherapeutics-Aktie (MLTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Moonlake Immunotherapeutics-Aktie (MLTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Moukheibir Catherine | Director |
Jul 03 '25 |
Sale |
48.79 |
23,500 |
1,146,565 |
0 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):